These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 8500773)

  • 21. Management of urinary tract infections, decubitus ulcer and pneumonia in the aging person.
    Ramírez-Ronda CH; Ballesté CR; Meléndez B; Vélez M; Fontán L; Saavedra S; González G
    Bol Asoc Med P R; 2003; 95(6):42-50. PubMed ID: 15449791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of oral fluoroquinolones in patients with respiratory diseases].
    Ishida T
    Kekkaku; 2003 Oct; 78(10):653-9. PubMed ID: 14621574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of newer antibiotics in gastroenterology.
    Li E; Stanley SL
    Gastroenterol Clin North Am; 1992 Sep; 21(3):613-29. PubMed ID: 1516960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 25. Resistance in gram-negative bacteria: enterobacteriaceae.
    Paterson DL
    Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P; Mandell L; Patou G; Dankner W; Tillotson G
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic decisions: assessing clinical fit.
    Barriere SL
    Pharmacotherapy; 1993; 13(2 Pt 2):18S-22S. PubMed ID: 8474933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
    Louie TJ
    CMAJ; 1994 Mar; 150(5):669-76. PubMed ID: 8313286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral ciprofloxacin in refractory gram-negative bacillary infections.
    Bryant RE; Hartstein AI
    Int J Clin Pharmacol Res; 1987; 7(3):187-94. PubMed ID: 3596862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quinolones: a comprehensive review.
    Oliphant CM; Green GM
    Am Fam Physician; 2002 Feb; 65(3):455-64. PubMed ID: 11858629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacology, clinical indications and toxicity of modern fluoroquinolones].
    Carvalho WA
    Rev Assoc Med Bras (1992); 1995; 41(4):293-304. PubMed ID: 8731611
    [No Abstract]   [Full Text] [Related]  

  • 32. Moxifloxacin (Avelox) for the treatment of bacterial skin infections.
    Parish LC; Witkowski JA; Routh HB
    Skin Therapy Lett; 2001 Oct; 6(11):1-2. PubMed ID: 11719825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging resistance problems among respiratory tract pathogens.
    Lister PD
    Am J Manag Care; 2000 May; 6(8 Suppl):S409-18. PubMed ID: 10977480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bacterial infections. Progress and new prospects in chemo-antibiotic therapy].
    Olivieri A; Fostini R; Xerri L; Recchia G
    Clin Ter; 1991 Jan; 136(1):53-61. PubMed ID: 1826874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational antibiotic treatment of outpatient genitourinary infections in a changing environment.
    David RD; DeBlieux PM; Press R
    Am J Med; 2005 Jul; 118 Suppl 7A():7S-13S. PubMed ID: 15993672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
    Fraise AP
    J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Quinolones].
    Lode H
    Schweiz Med Wochenschr; 1988 Dec; 118(49):1823-30. PubMed ID: 3064290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prulifloxacin: a new antibacterial fluoroquinolone.
    Prats G; Rossi V; Salvatori E; Mirelis B
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):27-41. PubMed ID: 16441207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current experience with quinolones in the treatment of urinary tract infection.
    Nicolle LE
    Clin Invest Med; 1989 Feb; 12(1):35-8. PubMed ID: 2920481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical perspectives on new antimicrobials: focus on fluoroquinolones.
    Talan DA
    Clin Infect Dis; 2001 Mar; 32 Suppl 1():S64-71. PubMed ID: 11249831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.